Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

James Louis Januzzi Jr., M.D.

Co-Author

This page shows the publications co-authored by James Januzzi and Hanna Gaggin.
Connection Strength

14.924
  1. Moving the Needle Toward a More Personalized Means of Patient Care. JAMA Cardiol. 2018 12 01; 3(12):1146-1148.
    View in: PubMed
    Score: 0.790
  2. Systematic Evaluation of Endothelin 1 Measurement Relative to Traditional and Modern Biomarkers for Clinical Assessment and Prognosis in Patients With Chronic Systolic Heart Failure: Serial Measurement and Multimarker Testing. Am J Clin Pathol. 2017 May 01; 147(5):461-472.
    View in: PubMed
    Score: 0.708
  3. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography. Circulation. 2017 Jan 10; 135(2):116-127.
    View in: PubMed
    Score: 0.687
  4. Serial Echocardiographic Characteristics, Novel Biomarkers and Cachexia Development in Patients with Stable Chronic Heart Failure. J Cardiovasc Transl Res. 2016 12; 9(5-6):429-431.
    View in: PubMed
    Score: 0.677
  5. Reference interval evaluation of high-sensitivity troponin T and N-terminal B-type natriuretic peptide in Vietnam and the US: The North South East West Trial. Clin Chem. 2014 May; 60(5):758-64.
    View in: PubMed
    Score: 0.568
  6. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure. JACC Heart Fail. 2014 Feb; 2(1):65-72.
    View in: PubMed
    Score: 0.565
  7. Natriuretic peptides in heart failure and acute coronary syndrome. Clin Lab Med. 2014 Mar; 34(1):43-58, vi.
    View in: PubMed
    Score: 0.563
  8. Soluble concentrations of the interleukin receptor family member ST2 and ß-blocker therapy in chronic heart failure. Circ Heart Fail. 2013 Nov; 6(6):1206-13.
    View in: PubMed
    Score: 0.553
  9. Biomarkers and diagnostics in heart failure. Biochim Biophys Acta. 2013 Dec; 1832(12):2442-50.
    View in: PubMed
    Score: 0.525
  10. Characterization and prediction of natriuretic peptide "nonresponse" during heart failure management: results from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) and the NT-proBNP-Assisted Treatment to Lessen Serial Cardiac Readmissions and Death (BATTLESCARRED) study. Congest Heart Fail. 2013 May-Jun; 19(3):135-42.
    View in: PubMed
    Score: 0.524
  11. Heart failure outcomes and benefits of NT-proBNP-guided management in the elderly: results from the prospective, randomized ProBNP outpatient tailored chronic heart failure therapy (PROTECT) study. J Card Fail. 2012 Aug; 18(8):626-34.
    View in: PubMed
    Score: 0.505
  12. What is the role of serial high-sensitivity troponin measurements in chronic heart failure? Clin Chem. 2012 Jul; 58(7):1079-81.
    View in: PubMed
    Score: 0.498
  13. Natriuretic peptide testing in heart failure. Circulation. 2011 May 10; 123(18):2015-9.
    View in: PubMed
    Score: 0.234
  14. Biomarkers in the management of heart failure. Curr Treat Options Cardiovasc Med. 2010 Dec; 12(6):519-31.
    View in: PubMed
    Score: 0.227
  15. Derivation and External Validation of a High-Sensitivity Cardiac Troponin-Based Proteomic Model to Predict the Presence of Obstructive Coronary Artery Disease. J Am Heart Assoc. 2020 08 18; 9(16):e017221.
    View in: PubMed
    Score: 0.222
  16. Proteomic Signatures During Treatment in Different Stages of Heart Failure. Circ Heart Fail. 2020 08; 13(8):e006794.
    View in: PubMed
    Score: 0.222
  17. Echocardiographic assessment of insulin-like growth factor binding protein-7 and early identification of acute heart failure. ESC Heart Fail. 2020 08; 7(4):1664-1675.
    View in: PubMed
    Score: 0.218
  18. Diagnostic and Prognostic Utilities of Insulin-Like Growth Factor Binding Protein-7 in Patients With Dyspnea. JACC Heart Fail. 2020 05; 8(5):415-422.
    View in: PubMed
    Score: 0.218
  19. Imaging, Biomarker, and Clinical Predictors of Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction. JACC Heart Fail. 2019 09; 7(9):782-794.
    View in: PubMed
    Score: 0.207
  20. Association of an HDL Apolipoproteomic Score With Coronary Atherosclerosis and Cardiovascular Death. J Am Coll Cardiol. 2019 05 07; 73(17):2135-2145.
    View in: PubMed
    Score: 0.204
  21. Effect of Neprilysin Inhibition on Various Natriuretic Peptide Assays. J Am Coll Cardiol. 2019 03 26; 73(11):1273-1284.
    View in: PubMed
    Score: 0.202
  22. A clinical, proteomics, and artificial intelligence-driven model to predict acute kidney injury in patients undergoing coronary angiography. Clin Cardiol. 2019 Feb; 42(2):292-298.
    View in: PubMed
    Score: 0.199
  23. Blood kidney injury molecule-1 predicts short and longer term kidney outcomes in patients undergoing diagnostic coronary and/or peripheral angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study. Am Heart J. 2019 03; 209:36-46.
    View in: PubMed
    Score: 0.198
  24. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T. J Am Coll Cardiol. 2018 11 06; 72(19):2309-2320.
    View in: PubMed
    Score: 0.197
  25. Endothelin-1 Measurement in Patients Undergoing Diagnostic Coronary Angiography-Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study. Clin Chem. 2018 11; 64(11):1617-1625.
    View in: PubMed
    Score: 0.195
  26. Type 2 Myocardial Infarction and the Hospital Readmission Reduction Program. J Am Coll Cardiol. 2018 09 04; 72(10):1166-1170.
    View in: PubMed
    Score: 0.194
  27. A clinical and proteomics approach to predict the presence of obstructive peripheral arterial disease: From the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study. Clin Cardiol. 2018 Jul; 41(7):903-909.
    View in: PubMed
    Score: 0.191
  28. N-Terminal Pro-B-Type Natriuretic Peptide in the Emergency Department: The ICON-RELOADED Study. J Am Coll Cardiol. 2018 03 20; 71(11):1191-1200.
    View in: PubMed
    Score: 0.188
  29. Single-Molecule Counting of High-Sensitivity Troponin I in Patients Referred for Diagnostic Angiography: Results From the CASABLANCA (Catheter Sampled Blood Archive in Cardiovascular Diseases) Study. J Am Heart Assoc. 2018 03 08; 7(6).
    View in: PubMed
    Score: 0.188
  30. Predicting new-onset HF in patients undergoing coronary or peripheral angiography: results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study. ESC Heart Fail. 2018 06; 5(3):240-248.
    View in: PubMed
    Score: 0.187
  31. Type 2 Myocardial Infarction - An Evolving Entity. Circ J. 2018 01 25; 82(2):309-315.
    View in: PubMed
    Score: 0.186
  32. Rationale and design of the ICON-RELOADED study: International Collaborative of N-terminal pro-B-type Natriuretic Peptide Re-evaluation of Acute Diagnostic Cut-Offs in the Emergency Department. Am Heart J. 2017 Oct; 192:26-37.
    View in: PubMed
    Score: 0.179
  33. Usefulness of Multiple Biomarkers for Predicting Incident Major Adverse Cardiac Events in Patients Who Underwent Diagnostic Coronary Angiography (from the Catheter Sampled Blood Archive in Cardiovascular Diseases [CASABLANCA] Study). Am J Cardiol. 2017 07 01; 120(1):25-32.
    View in: PubMed
    Score: 0.176
  34. Type 2 myocardial infarction due to supply-demand mismatch. Trends Cardiovasc Med. 2017 08; 27(6):408-417.
    View in: PubMed
    Score: 0.175
  35. Circulating Concentrations of Orexin A Predict Left Ventricular Myocardial Remodeling. J Am Coll Cardiol. 2016 11 15; 68(20):2238-2240.
    View in: PubMed
    Score: 0.171
  36. Insulin-Like Growth Factor-Binding Protein-7 as a Biomarker of Diastolic Dysfunction and Functional Capacity in Heart Failure With Preserved Ejection Fraction: Results From the RELAX Trial. JACC Heart Fail. 2016 11; 4(11):860-869.
    View in: PubMed
    Score: 0.170
  37. Established and Emerging Roles of Biomarkers in Heart Failure Clinical Trials. Circ Heart Fail. 2016 09; 9(9).
    View in: PubMed
    Score: 0.169
  38. Worsening Renal Function during Management for Chronic Heart Failure with Reduced Ejection Fraction: Results From the Pro-BNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study. J Card Fail. 2017 Feb; 23(2):121-130.
    View in: PubMed
    Score: 0.168
  39. Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study. Arterioscler Thromb Vasc Biol. 2016 08; 36(8):1692-7.
    View in: PubMed
    Score: 0.167
  40. The Importance of Worsening Heart Failure in Ambulatory Patients: Definition, Characteristics, and Effects of Amino-Terminal Pro-B-Type Natriuretic Peptide Guided Therapy. JACC Heart Fail. 2016 09; 4(9):749-55.
    View in: PubMed
    Score: 0.165
  41. Effects of Optimism and Gratitude on Physical Activity, Biomarkers, and Readmissions After an Acute Coronary Syndrome: The Gratitude Research in Acute Coronary Events Study. Circ Cardiovasc Qual Outcomes. 2016 Jan; 9(1):55-63.
    View in: PubMed
    Score: 0.161
  42. Design and baseline data from the Gratitude Research in Acute Coronary Events (GRACE) study. Contemp Clin Trials. 2015 Sep; 44:11-19.
    View in: PubMed
    Score: 0.156
  43. Concentrations of highly sensitive cardiac troponin-I predict poor cardiovascular outcomes and adverse remodeling in chronic heart failure. J Cardiovasc Transl Res. 2015 Apr; 8(3):164-72.
    View in: PubMed
    Score: 0.153
  44. Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction. Am Heart J. 2015 Mar; 169(3):404-411.e3.
    View in: PubMed
    Score: 0.151
  45. Characterization and prediction of adverse events from intensive chronic heart failure management and effect on quality of life: results from the pro-B-type natriuretic peptide outpatient-tailored chronic heart failure therapy (PROTECT) study. J Card Fail. 2015 Jan; 21(1):9-15.
    View in: PubMed
    Score: 0.148
  46. Prognostic usefulness of insulin-like growth factor-binding protein 7 in heart failure with reduced ejection fraction: a novel biomarker of myocardial diastolic function? Am J Cardiol. 2014 Nov 15; 114(10):1543-9.
    View in: PubMed
    Score: 0.147
  47. Measurement of novel biomarkers to predict chronic heart failure outcomes and left ventricular remodeling. J Cardiovasc Transl Res. 2014 Mar; 7(2):250-61.
    View in: PubMed
    Score: 0.140
  48. Serial measurement of galectin-3 in patients with chronic heart failure: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Eur J Heart Fail. 2013 Oct; 15(10):1157-63.
    View in: PubMed
    Score: 0.134
  49. Improvement in structural and functional echocardiographic parameters during chronic heart failure therapy guided by natriuretic peptides: mechanistic insights from the ProBNP Outpatient Tailored Chronic Heart Failure (PROTECT) study. Eur J Heart Fail. 2013 Mar; 15(3):342-51.
    View in: PubMed
    Score: 0.130
  50. Quality of life and chronic heart failure therapy guided by natriuretic peptides: results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) study. Am Heart J. 2012 Nov; 164(5):793-799.e1.
    View in: PubMed
    Score: 0.130
  51. Mid-regional pro-atrial natriuretic peptide and pro-adrenomedullin testing for the diagnostic and prognostic evaluation of patients with acute dyspnoea. Eur Heart J. 2012 Sep; 33(17):2197-205.
    View in: PubMed
    Score: 0.126
  52. Use of amino-terminal pro-B-type natriuretic peptide to guide outpatient therapy of patients with chronic left ventricular systolic dysfunction. J Am Coll Cardiol. 2011 Oct 25; 58(18):1881-9.
    View in: PubMed
    Score: 0.121
  53. Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T. Eur J Heart Fail. 2020 11; 22(11):2078-2088.
    View in: PubMed
    Score: 0.053
  54. Revisiting the obesity paradox in heart failure: Per cent body fat as predictor of biomarkers and outcome. Eur J Prev Cardiol. 2019 11; 26(16):1751-1759.
    View in: PubMed
    Score: 0.051
  55. High-sensitivity troponin T, NT-proBNP and glomerular filtration rate: A multimarker strategy for risk stratification in chronic heart failure. Int J Cardiol. 2019 Feb 15; 277:166-172.
    View in: PubMed
    Score: 0.049
  56. Association of Cardiovascular Biomarkers With Incident Heart Failure With Preserved and Reduced Ejection Fraction. JAMA Cardiol. 2018 03 01; 3(3):215-224.
    View in: PubMed
    Score: 0.047
  57. Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis. Circulation. 2018 01 16; 137(3):286-297.
    View in: PubMed
    Score: 0.046
  58. Predictors and outcomes of heart failure with mid-range ejection fraction. Eur J Heart Fail. 2018 04; 20(4):651-659.
    View in: PubMed
    Score: 0.046
  59. Associations Between Psychological Constructs and Cardiac Biomarkers After Acute Coronary Syndrome. Psychosom Med. 2017 Apr; 79(3):318-326.
    View in: PubMed
    Score: 0.044
  60. A Clinical and Biomarker Scoring System to Predict the Presence of Obstructive Coronary Artery Disease. J Am Coll Cardiol. 2017 Mar 07; 69(9):1147-1156.
    View in: PubMed
    Score: 0.044
  61. Prognostic Value of Insulin-Like Growth Factor-Binding Protein 7 in Patients with Heart Failure and Preserved Ejection Fraction. J Card Fail. 2017 Jan; 23(1):20-28.
    View in: PubMed
    Score: 0.042
  62. Diagnostic and Prognostic Utility of Procalcitonin in Patients Presenting to the Emergency Department with Dyspnea. Am J Med. 2016 Jan; 129(1):96-104.e7.
    View in: PubMed
    Score: 0.039
  63. Analysis of BAG3 plasma concentrations in patients with acutely decompensated heart failure. Clin Chim Acta. 2015 May 20; 445:73-8.
    View in: PubMed
    Score: 0.038
  64. Comparison between admission natriuretic peptides, NGAL and sST2 testing for the prediction of worsening renal function in patients with acutely decompensated heart failure. Clin Chem Lab Med. 2015 Mar; 53(4):613-21.
    View in: PubMed
    Score: 0.038
  65. Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study. PLoS One. 2014; 9(11):e112313.
    View in: PubMed
    Score: 0.037
  66. Different vascular responses within the same stent detected by optical coherence tomography. Coron Artery Dis. 2014 Aug; 25(5):450-1.
    View in: PubMed
    Score: 0.037
  67. Usefulness of combining galectin-3 and BIVA assessments in predicting short- and long-term events in patients admitted for acute heart failure. Biomed Res Int. 2014; 2014:983098.
    View in: PubMed
    Score: 0.036
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.